Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 1, 2021 | Immunitas Therapeutics | $58.0M Series B | Agent Capital | Alta Partners, Cofounders Capital, Domain Associates, Leaps by Bayer, Longwood Fund, Novartis Venture Fund, Providence Ventures, RA Capital, Section 32, Netalie Nadivi, Alexandria Venture Investments, Evotec, Brian Halak, Mirae Asset, M Ventures, Novartis, NS Investment, Ono Venture Investment, Solasta Ventures, The Leukemia & Lymphoma Society, The Mark Foundation for Cancer Research |